Bailard, Inc. Haemonetics Corp Transaction History

Bailard, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	BUY	$82.56 - $93.49 $24,768 - $28,047	300 Added 11.83%	2,835 $253,000
Q2 2023 Jul 20, 2023	BUY	$80.84 - $89.45 $204,929 - $226,755	2,535 New	2,535 $215,000
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $571,246 - $727,583	-6,350 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$71.53 - $95.75 $1,788 - $2,393	-25 Reduced 0.39%	6,350 $569,000
Q1 2018 May 07, 2018	BUY	$60.72 - $74.41 $387,090 - $474,363	6,375 New	6,375 $466,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.